Sarep­ta faces an­oth­er gene ther­a­py hic­cup as Re­genxbio sues over Jim Wilson's patent

It turns out a reg­u­la­to­ry de­lay isn’t the on­ly bump on Sarep­ta’s road to gene ther­a­py glo­ry.

The biotech is be­ing sued by Re­genxbio, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.